Tranquis Therapeutics Launches with $30 Million Series A Funding to Advance Novel Immuno-Neurology Approach to Treating Neurodegenerative and Aging-related Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2W0J1kP
via IFTTT